 AIkido Pharma Inc. Nasdaq: AIKI today announced execution of an Artificial Intelligence AI, and Machine Learning ML research agreement with Cogia Biotech LTD Cogia to accelerate the Companys pancreatic cancer genetic marker research. Cogia is a Big-data, AI, and ML software company committed to using powerful AI engines and algorithms to develop compelling outcomes in drug development. Cogia provides state-of-the-art digital information and discovery tools to subject-matter experts and scientists working in genetics and cancer research, to advance drug development. Cogias existing clients include many international companies, including international pharmaceutical companies. 